COMP <GO>
IRTC vs MRK // PIOTROSKI F-SCORE QUALITY
iRhythm Holdings Inc. (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: IRTC 3
— MRK 10
■ METRIC PARITY
LAST: $123.37 (-3.47%) • MKT CAP: $4.21B
piotroski-score
7/9
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IRTC VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IRTC | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 70.60% | 74.80% | -4.20 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -13.50% | 20.70% | -34.20 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.82% | 3.42% | -2.60 | MRK | /fcf-yield <GO> |
| Operating Margin | -7.70% | 34.30% | -42.00 | MRK | /operating-margins <GO> |
| Net Profit Margin | -6.00% | 28.10% | -34.10 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 26.20% | 1.30% | +24.90 | IRTC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.01 | 5.19 | -2.18 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.60% | +0.20 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.2 | 56.9 | +6.32 | IRTC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 0.92 | +0.06 | IRTC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.0x | 18.4x | +11.60 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.21B | $361.02B | -$356.81B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IRTC REV | MRK REV | IRTC GROSS % | MRK GROSS % | IRTC FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $747.1M | $65.01B | 70.6% | 74.8% | $34.5M | $12.36B |
| FY 2024 | $591.8M | $64.17B | 68.9% | 76.3% | -$30.6M | $18.10B |
| FY 2023 | $492.7M | $60.12B | 44.0% | 44.0% | -$72.3M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IRTC // BETA 0.98
MRK // BETA 0.92